Topic Hub

Pde5 Inhibitors — Drug Class Monograph

2 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

2articles

19keywords mapped

2026-05-27latest review

Explore

Pde5 Inhibitors — Drug Class Monograph library

Showing 2 of 2 clinical reviews.

Clinical Reviews2026-05-27

PDE5 Inhibitors Drug-Drug Interaction Table

Complete drug-drug interaction (DDI) reference for PDE5 inhibitors including sildenafil, tadalafil, vardenafil, and avanafil. CYP3A4 interactions, nitrate contraindications, alpha-blocker timing, and dose adjustments for prescribers.

Read clinical review

Dosing & Monitoring2026-05-27

PDE5 Inhibitors Monitoring Bundle: Labs, Timelines, and Clinical Checkpoints

A prescriber-level guide to the PDE5 inhibitor monitoring bundle, including baseline labs, on-treatment surveillance, cardiovascular screening, and follow-up intervals for sildenafil, tadalafil, vardenafil, and avanafil.

Read clinical review